Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group
Background: In node-negative breast cancer (NNBC), a high risk of recurrence is determined by clinico-pathological or tumor-biological assessment. Taxanes may improve adjuvant chemotherapy. Methods: NNBC 3-Europe, the first randomized phase-3 trial in node-negative breast cancer (BC) with tumor-biol...
Main Authors: | Christoph Thomssen, Martina Vetter, Eva J. Kantelhardt, Christoph Meisner, Marcus Schmidt, Pierre M. Martin, Florian Clatot, Doris Augustin, Volker Hanf, Daniela Paepke, Wolfgang Meinerz, Gerald Hoffmann, Wolfgang Wiest, Fred C. G. J. Sweep, Manfred Schmitt, Fritz Jänicke, Sibylle Loibl, Gunter von Minckwitz, Nadia Harbeck |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/5/1580 |
Similar Items
-
THE EORTC AND THE EORTC BREAST CANCER GROUP
by: Therasse Patrick
Published: (2005-01-01) -
A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group.
by: Hall, J, et al.
Published: (2014) -
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis
by: Serce Nuran Bektas, et al.
Published: (2012-12-01) -
Author Correction: Translation and validation of the EORTC QLQ-BR45 among Ethiopian breast cancer patients
by: Mikiyas Amare Getu, et al.
Published: (2022-12-01) -
Mitogenome analysis of a green tide forming Ulva from California, USA confirms its identity as Ulva expansa (Ulvaceae, Chlorophyta)
by: Jeffery R. Hughey, et al.
Published: (2018-07-01)